<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 84 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page83.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=84">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 84 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 84</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=84"><img src="../thumb/84.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anaesthetics / Analgesics - 2.3 / 3 / 3.1                                       2020-04 / 53
       Indications: Gen.anaesthes.adjuct.to facilit. tracheal intubat.dur.  Dos.titrat.& maint.ther: Pts.may req.dos. incr.aft.intit.applicat.as   UTI, change in body temp.feel., pyrex., fatig., malaise, flu-like illn.,
       rout.& rapid sequence induct. & skelet. musc.relaxat.dur.surg., ad-  convers.ratio from morphine is conservat. Perform dos.titrat.in in-  periph. oed., asthen., drug withdr.syndr., anaphylax., anaphylactoid
                                              nd
                                                 rd
       junct in ICU to facilit. intubat.& mechanic.ventilat.for up to 3 days   crem.of 25 µg/h dur.2  or 3  day of applicat. Six days poss.reqd.  react., hallucinat., euphor. mood, agitat., convuls., amnes., head-
       in adults 18-65 yrs.          to reach equilibrium aft.each dos.incr.theref.high. dos. should be   ache, trem., tachycard., bradycard., hypo-/hypertens., resp. de-
       (S4) SOL FOR IV INJ, 30/17.1/0192. 50 mg/5 ml.  worn x72 hr.bef.furth.incr. made. More than 1 patch may be used   press., hypoventilat., dyspn., jaund., incr. sweat., urin. retent., sex.
       821691-007, 10x5 ml vials, R1 653,87  for dos.&gt; 100 µg/h,  dysfunct., drug withdr. syndr., applic. site reacts., stupor, cough., tol.,
       For further details refer to manuf.product lit.  Discontinuat: Withdr.grad.and replace grad. with other analges.  depend., psych. depend.
       MIVACRON 5, (Aspen Pharmacare)    start.at low dos. incr.slow.  Warnings and special precautions: Ser./life-threat. hypoventi-
                                     Contraindications: Safety & effic.in childr. not est., safety in pregn.&
       Pharmacare [P/S]              lactat.not est., diarrh.assoc.with pseudomemebr. colit. / poison., resp.  lat.poss.& no short-term dos. titrat. poss.if used for ac./post-op pain
                                                                  theref.not recomm., in case of prev.opiod.toxic.monit.for at least
       Mivacurium as mivacurium chloride.  depress/dis., asthma, inflammat. bowel dis.
       Indications: Adjunct.to gen.anaesth.to relax skelet.musc., to facilit.  12-24 h.aft.removal of patch, keep out of childr. reach bef.& aft.use,
       trach.intubat.& mechan. ventilat.  Side effects: Arrhythm., bradycard., amblyop., GI disturbs., papules,   recomm.to use in pts. demonstrat. opioid tol.as life threat.hypoven-
                                     chest pain, oed., pustules, anorex., asthen., hyperton., hypoton., CNS
       (S4) INJ, 27/17.1/0569                                     tilat. potent. exists even when ther.init.at low.dos.in opioid naïve
       800449-002: 2 mg/ml, 5x5 ml amps, R642,48  effs.incl.CNS depress & stupor/ hallucinat./paranoid react.& deper-  pts., monit.for resp.depress.even aft. patch remov., opioid withdr.
                                     sonalisat., hostility & ac.tox.delirium, urin.retent./-freq., bladd.pain,
       For further details refer to professional info             sympts.poss.aft. convers./ dos.adjustm., COPD & other pulm.dis.,
                                     oligur., hypoventilat., apnoea, haemoptys., resp. disord., asthma,   tol./ physic. depend.& psychology.depend.& abuse developm., pts.
       NIMBEX, (GSK) GlaxoSmithKline [P/S]  dyspn., pharyngit., hiccups, stertor. breath., sweat., erythema, itch.,   suscept.to intracran.eff.of CO 2 retent., brain tumour, clinic.course of
       Cisatracurium as besylate.    exfoliat. dermatit., prurit., rash, hypotens., hypertens.  head injur. obscur., bradyarrhythm., imp.ren./hepat.funct., fev., avoid
       Indications: Skelet.musc.relax.in anaesthes.& to facilitate con-  Special precautions: Not appropr.for ac./ post-op pain as ser./  applic.site expos.to direct heat source, concom. meds affect. sero-
       trolled ventilat.             life threat.hypoventilat. poss. & no short term use dos.titrat.poss..   tonerg.neurotransmitt. syst. as serotonin syndr.poss., monit.pt.esp.
       (S4) INJ. 31/17.1/0256.       monit. x12-24h.aft.removal of patch as ser. conc.decr.slow., distribut.  for resp. depress.if used concom.with CYP3A4 inhibits., elderly, not
       827983-018: 5 mg/ml, 1x30 ml vial, R876,54  in breast milk, heat expos.as fentanyl conc.incr.with incr. skin temp.,   stud.in childr.und.2 yrs., only admin.to opiod-tol.childr.2yrs and old.,
       For further details refer to professional info  fev., myasth.grav., pulm.dis.as respirat.drive decr.& airway resist.incr.,   pass. through placenta, resp.depress.in newborn if giv. dur. childbirth,
       ROCURONIUM FRESENIUS, Fresenius Kabi [P/S]  tol./ depend.& abuse developm., pts.suscept.to intracran. eff.of CO 2   neonat.withdr.syndr.with chron. matern. use., excret.in breast milk,
                                     retent., clinic.course of head injur.obscur., bradyarrhythm., imp. ren./
                                                                  drug & alcoh. abuse hist.esp.if outside medic.control.environm., con-
       Rocuronium bromide            hepat.funct., elderly, drug & alcoh. abuse hist., driv.and hazard.tasks,
       Indications: Gen.anaesthes.adjuct.to facilit. tracheal intubat.dur.  Drug interactions: Addit.depress.eff.with alcoh./sedat./tranquilis &   com. MAOI’s not recomm.
                                                                  Interactions: Metabol.main.by CYP3A4 incr. plasma conc., oral rito-
       rout.& rapid sequence induct. & skelet. musc.relaxat.dur.surg., ad-  phenothiaz., CYP3A4 induc.may incr. clear., CYP3A4 inhibit. may decr.
       junct in ICU to facilit. intubat.& mechanic.ventilat.for up to 3 days   clear., ineffect.with naltrexone as therapeut.effs.block.  navir reduc. IV fentanyl clear., addit.depress.eff.with other CNS de-
       in adults 18-65 yrs.                                       press., poss. potent. of opiate/serotoninerg.effs.with MAOI’s, serot.
       (S4) SOL FOR INJ/INFUS, 46/17.1/0061. 10 mg/ml.  DF-118, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  syndr.risk with concom.SSRI/SNRI.
       3000885-001: 1x5 ml vial, R86,25  Dihydrocodeine tartrate.  FENDERMAL, Sandoz [N/P/S in C]
       3000885-002: 10x5 ml vials, R862,50  Indications: Pain.    Fentanyl
       For further details refer to manuf.product lit.  (S6) INJ, [P/S] B730. 50 mg/ml.  Indications: Chron.intract.pain managem.requir. opioid analges.
                                     719374-006: 5x1 ml, R366,03  which cannot be managed by less.means.
       SUXAMETHONIUM CHLORIDE FRESENIUS, Fresenius   719374-007: 10x1 ml, R732,06  (S6) TRANSDERM.THERAPEUT.SYSTM, 44/2.9/0757,0758,
       Kabi [P/S]                    Dosage: Up to 50 mg IM/deep SC.  0759, 0760
       Suxamethonium chlor.          (S6) TABS, [P/S] B726.       719279-001: 25 µg/h, 5, R456,61
       Indications: Facilit.endotrach.intub./ bronchoscopy /oesophagos-  719382-009: 30 mg, 100, R667,00  719280-001: 50 µg/h, 5, R763,72
       copy in combin.with gen. anaesth.& resp.support, rapid short-term   Dosage: Adults: 30 mg 4-6 hrly with/aft.meals.  719281-001: 75 µg/h, 5, R1,057,36
       musc. relax.in orthopaed.proced.with resp. support, as adjuv.in surg.  Contraindications: Childr.  719282-001: 100 µg/h, 5, R1 360,47
       anaesthes.to obtain. skelet. musc.relax.esp.of abdom.wall to facilit.   Side effects: Constip., naus., gidd.  Dosage: Admin.only by indiv.exper.in contin. potent.opioid admin-
       operat.manipulat.             Special precautions: Asthmat., not dur.asthma attack, imp.hepat.  istrat. Do not div./cut patch. Indiv.dos.& assessm. at reg.interv.as
       (S4) INJ. M/17.1/270. 100 mg/2 ml  funct., caut.dur.pregn., tabs. cont.lact.  toler.varies betw.indiv. Apply to dry, non-irrit.& non irradiat. skin on
       768170-001: 10x2 ml, R117,30                               flat surf.of torso & upper arms. Patch must be worn contin. x72 hrs.
       For further details refer to manufact.prod.lit.  DUROGESIC, Janssen Pharmaceutica [N/P/S in C] &
                                     Fentanyl.                    Opioid naive pts: Init.dos.not to exceed 25 µg/h.
                                     Indications: Chron.intract.pain managem.requir. opioid analges.  Opioid-tolerant pts: To convert opioid-tol.pts. from oral/parenter.
                                     which cannot be managed by less. means  opioids to Fendermal refer to equianalges. potency convers.tables
       3      ANALGESICS             (S6) TRANSDERM.THERAPEUT.SYSTEM. A40/2.9/0203,   on package insert.
                                                                  Switch.from other opioids: To calc.dos.when chang.from oral/
                                     28/2.9/0288, 0289, 0290, 0291.
                                     711169-001: 12 µg/h, 5, R298,00  parenter.opioids to fentanyl determ. analges.quant.reqd.over past
       3.1    Narcotic analgesics    814008-003: 25 µg/h, 5, R674,85  24 hrs. & convert sum obtain.to corresp.to oral morph.dos. and then
                                                                  determ.corresp.fentanyl dos.using tables in prod.lit.
                                     814016-006: 50 µg/h, 5, R1 117,12
       OXYNORM (MDR Listing)         819425-001: 75 µg/h, 5, R1 538,80  Eval.of max.analges.eff.not to be made bef.patch has been worn for
                                                                                           st
       SOVENOR (MDR Listing)         814024-009: 100 µg/h, 5, R1 969,87  24 hrs. Pt.may contin.to receiv. prev.analges.at prev.dos.in 1  12 hrs
       TARGINACT (MDR Listing)       Dosage: Prescrib.only by indiv.exper.in continuous potent.opioid ad-  aft.chang.to Fendermal then admin.as need.over next 12 hrs & grad.
       TEMGESIC (MDR Listing)        ministrat. Indiv. Assess.at reg. interv. aft.applic. Patch.deliv.approx.12,   phas.out once Fendermal analges.effic.reach.
                                     25, 50, 75 & 100 µg/h fentanyl to system.circulat.which repres. 0,3-   Dos.titrat.& maint.ther: Replace patch every 72 hrs. Indiv.dos.titrat.
       A-LENNON CODEINE, (Aspen Pharmacare: Pharma)   0,6- 1,2- 1,8- & 2,4 mg/day respect. Init. dos.select.based on current   until analg.effic.reach.
       Pharmacare [P/S]              opioid use/pt. gen. condit./medic.status/debilit.extent/opioid tol. Ap-  In pts.exper.a mark.decr.48-72 hrs aft.applic. Fendermal replacem.
       Codeine phosphate.            ply to dry, non-irrit.& non irradiat.skin on flat surf. of torso & upper   may be need.aft.48 hrs. Dos. may be incr.aft.3 days if analges.insuf-
       Indications: Mod.pain.        arms. Do not use cut/divid./ damaged patch. Eval.analges.eff.aft 24   fic.aft. init. applic.based on the dly.supplem.analges.dos. reqd. on 2   nd
                                                                    rd
       (S6) TABS. B1192.             hrs. Grad. phase out prev.analges.ther.aft.init applicat.until analges.   or 3 .day of init.applic. Thereaft.dos. adjustm. may be made every
       715123-009: 30 mg, 100, R537,77  effic.with Durogesic is attain.  3 days. Six days poss. reqd.to reach equilibr.on new dos. Pt.to wear.
       Dosage: 15-60 mg dly.         Adults: Opioid-tolerant pts: See conversion tables on package in-  high. dos.through 2 applic.bef.furth.dos.incr.made. Dos.adjustm.to
       Contraindications: Resp.depress., ac.alcohol., rais. IC-press., head   sert for opioid-tol.pts. Subseq. titrat. upwards/downwards as reqd.in   be made in 25 µg/h increm.depend. on supplem.analges.requirem./
       injur., ac.bronch.asthma attack, HF second.to chron.lung dis., MAOI’s.  12 or 25 µg increm. to achieve low.appropr.dos.depend.on respons.   pt.status. Pt.may need period.short-act.analges.supplem.dos.for
       Side effects: GI disturbs., CNS effs., dry mouth, sweat., fac.flush.,   & supplem.analges.requirem.  breakthrough pain. Addit./alt.analges.methods/ alt.opioid admin.to
       vertigo, bradycard., palpitat., orthostat.hypotens., hypothermia, dif-  Opioid-naïve pts: Clinic.exper.limit. Titrat.with low dos.of immed.rel.  be consid.if Fendermal dos exceed.300 µg/h. Short-act.morph.in low
       fic.micturit., ureter./bil.spasm, anti-diuret.eff., rais.IC-press., urticar.,   opioids to attain equianalges. dos.to Durogesic 25 µg/hr. Then con-  dos. advis. in case of withdr.sympt.
       prurit., cont.dermatit.       vert to Durogesic 25 µg/hr. Subseq.titrat. upwards/ downwards as   Discontinuat: Withdr.grad.& replace with other opioids start.at
       Special precautions: Poss.depend./addict., hypothyroid., adreno-  reqd.in 12 or 25 µg increm. to low.appropr.dos. depend.on respons.&   low dos.incr.slow.
       cort.insuff., imp.liv.funct., prostat.hypertrophy, shock, elderly & debili-  supplem. analges.requirem.  Contraindications: Ac./post-op pain, mild/ intermit. pain that can
       tat., inflamm./ obstruct.bowel disords., myasthen. grav., resp.depress.   Paediatrics: Opioid-tol.pts.(2-16 yrs): Admin. only to pts. already   be manag.with less potent analges./ as-need.short-intermed.-act.
       in neonates.if admin.dur. labour, cont.lact.  receiv.at least 30 mg oral morphine equiv./day. To convert see con-  opioid analges. admin., ac./exist.resp.depress., coma, bradycard.
       Drug interactions: Depress.effs.enhanc.by other CNS depress.  version tables on package insert.  dysrhythm., sev.impair.CNS funct., dur. labour & deliv., safety in
       ADCO TENYL, AI Pharm [N/P/S in C]  Dos.titrat.& maint.ther: Replace every 72 hrs. Titrate dos.indiv.until   pregn.& lactat.not est., childr. und.12 yrs., ritonavir & potent cyto-
       Fentanyl.                     bal.betw.analges.effic.& tolerab. achiev. If analges.is insuffic.aft.init.  chrom. P450 3A4 inhibits., concom.alcoh., concom.MAOI/ naltrex-
       Indications: Chron.intract.pain managem. requir. opioid analges.  applic. it may be incr.aft.3 days based on dly.dos.of supplem. anal-  one, bronch.asthma.
       which cannot be managed by less.means  ges.reqd.in 2nd & 3rd.day of init. applicat. Thereaft.dos.adjustm.can   Side effects: Resp.depress./distress, anaphylact. shock/ anaphy-
       (S6) TRANSDERM.THERAPEUT.SYSTM, 41/2.11/0255, 0256,   take place every 3 days.  lactoid reacts., psych.disords.incl. hallucinat./ delus./insomn./ac.tox.
       0257, 0258                    It may take 6 days aft.incr.dos.for pt.to reach equilibrium on new   delir., CNS effs. incl.headache/dizzin./somnol., trem., paraesthes.,
       716797-001: 25 µg/h, 5, R484,19  dos.,therefore pts.should wear a higher dos. through 2 applic.bef.  paranoia, imp.co-ordinat., seiz., amblyop., vertigo, bradycard., tachy-
       716798-001: 50 µg/h, 5, R801,53  any furth.incr is made on basis of aveg.dly.supplem.analges. Titrate   card., dysrhythm., hypotens., hypertens., vasodilat., apnoea, breath.
       716799-001: 75 µg/h, 5, R1 104,09  in 12 µg/ h or 25 µg/h increm.tak.into account. supplem. analges.&   diffic., hypovent., asthma, bradypnoea., GI disturbs., hiccups, ileus,
       716800-001: 100 µg/h, 5, R1 413,39  pain status of pt. More than 1 patch may be used for dos.&gt; 100 µg/h,   skin reacts.incl.diaphores., exanthema, prurit., urin. retent., cystalg.,
       Dosage: Admin.only by indiv.exper.in continous potent.opioid ad-  Period.supplem.dos.of short-act. analgesics poss.reqd.for break-  oligur., weakn., loc.reacts., asthen., withdr.sympt., oed., cold sens.
       ministrat. Indiv. dos.& assess.at reg.interv.as tol.varies widely betw.  through pain. Addit./ alternat.methods may be reqd.for dos. exceed.   Special precautions: Pass.through placenta, pass. into breast
       indiv. Apply to dry, non-irrit.& non irradiat.skin on flat surf.of torso &   300 µg/h. If discont. replace grad.with other opioids at low dos.incr.  milk, not appropr.for ac./post-op pain as ser./life threat.hypoventilat.
       upper arms. Patch may be worn contin.x72 hrs.  slowly as fentanyl lev. fall grad.aft.remov.  poss.& no short term use dos.titrat.poss., monit.opioid-toxic. pts. for at
       Init.dos.                     Contraindications: Pregn.& lactat., childr.less than 2 yrs., hyper-  least 12-24 hrs aft.patch remov., COPD, remove patch immed./keep
       Pts.not opioid tolerant: Low.dos.of 25 µg/h to be used.  sens.to patch adhesiv., concom. CYP3A4 inhibit.not recomm.un-  pt.awake if resp. depress.occurs, maint./recurr.resp.depress.poss.
       Opioid-tolerant pts: Quantity equiv.to pts. curr.24 hr.analges.re-  less closely monit  aft.patch remov.as has half-life of 17 hrs., pts. suscept. to intracran.
       quirem. See conversion tables on package insert for opioid-tol.pts.   Side effects: Anorex., psych.effs., somnol., insomn., anx., depress.,   eff.of CO 2 retent., drug/alcoh. depend., ren./hepat.funct., elderly,
       Evaluat.analges.eff.aft 24 hrs. Phase out prev. analges.until Adco   dizzin., invol.musc. contract., hypo-/paraesthes., conjunctivit., palpi-  heat expos.as fentanyl conc.incr.with incr.skin temp., fev., myasth.
       Tenyl reaches analges. effic.  tat., yawn., rhinit., GI disturbs., dry mouth, skin reacts., hyperhidros.,   grav., phys.activ., debilit.pts./low body mass, switch.fentanyl-cont.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page83.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page79.html">79</a>&nbsp;&nbsp;&nbsp;<a href="page80.html">80</a>&nbsp;&nbsp;&nbsp;<a href="page81.html">81</a>&nbsp;&nbsp;&nbsp;<a href="page82.html">82</a>&nbsp;&nbsp;&nbsp;<a href="page83.html">83</a>&nbsp;&nbsp;&nbsp;<a href="page84.html">84</a>&nbsp;&nbsp;&nbsp;<a href="page85.html">85</a>&nbsp;&nbsp;&nbsp;<a href="page86.html">86</a>&nbsp;&nbsp;&nbsp;<a href="page87.html">87</a>&nbsp;&nbsp;&nbsp;<a href="page88.html">88</a>&nbsp;&nbsp;&nbsp;<a href="page89.html">89</a>
             </td>
             <td width="35%"><a href="page85.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page85.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
